This week, as part of our v13.0.0 major release, our customers gained access to the expanding QuartzBio Learning Lab – a centralized, easy-to-navigate hub for training, product documentation, and updates.
Flexible, On-Demand Access: Users can complete training anytime and anywhere, minimizing disruption to daily operations.
Role-Based Learning Paths: Targeted content aligned with specific use cases ensures relevance and efficiency.
Compliance Assurance: Track training completions and maintain audit-ready records to meet regulatory requirements with confidence.
Highlights of other new features launched in v13.0.0:
Sharable Homepages for Better Collaboration: Align teams and stakeholders with custom homepages that you can share at user or organization levels.
Snowflake Integration for Faster Insights: Experience seamless interoperability with your Snowflake data environment and perform advanced data operations.
New Dashboards for Sample Intelligence: Get more visibility into non-compliant collections and future collections, to keep trials on track (Figure 1).
Mutation Data Access for Richer Analyses: Perform more detailed analysis of genetic variations.
Figure 1. New Non-Compliant Data Collections Dashboard features 6 configurable visualizations that make it easy to monitor missing, partial, and out-of-protocol sample collections.
What’s coming next in QuartzBio’s product roadmap? Contact us to discuss – we’re always open to hearing your ideas.
ICH E6(R3) is here, and places significant responsibility on sponsors to maintain quality across sample and biomarker data lifecycles. Both noncompliance and compliance have serious costs.
Disconnected sample and biomarker data workflows may be invisibly driving up costs of compliance, given that an average clinical trial can encounter tens of thousands of data issues, depending on the phase and complexity.
Request our white paper to see our breakdown of the costs associated with achieving and maintaining compliance using traditional processes and point solutions.
You’ll also learn how QuartzBio’s platform approach transforms compliance processes, helping customers lower costs immediately, reducing compliance issues and data problems by over 80%.
https://quartz.bio/wp-content/uploads/2025/10/LinkedIn_ICH-White-Page_1200x1200_Update-1.jpg12001200Chandreyee Dashttps://quartz.bio/wp-content/uploads/2026/05/2026-QB-Logo_New-Brand-Update_QB-DK-Blue.pngChandreyee Das2025-10-30 13:59:512026-09-11 13:47:13Revealing the true costs of ICH E6(R3) compliance & noncompliance
If you’re a current customer, please reach out to your QuartzBio Project Manager to learn more about accessing these features!
Highlights of What’s New:
Larger file sizes (uploads can be up to 200 Gb or more) improve support for large data sets and multimodal insights.
Dynamic sample analytics: Flexible new Sample Intelligence data tables and dashboards, including new data quality dashboards (Figure 1), provide a user-friendly alternative to static HTML reports.
More accurate sample forecasting: Project visits beyond study end dates.
Richer insights: Detailed clinical response data available in Biomarker Intelligence data tables. You can now publish clinical response data types “status” and “grade” to your analysis-ready data asset (Figure 2).
Figure 1. Examples of new sample data quality dashboard options: Gain insights into discrepancies in sample data across multiple systems (Central Lab, Testing Lab, EDC) to support data quality and integrity in clinical studies.
Figure 2. Clinical response “Grade” and “Status” are now options for adding to your Biomarker Intelligence data tables. These values can then be used for analysis via swimmer and waterfall plots, for rich clinical insights.
What’s coming next in QuartzBio’s product roadmap? Contact us to join our upcoming Innovation Summits — we’ll be gathering input from sponsor teams and sharing previews of new features.
https://quartz.bio/wp-content/uploads/2026/05/2026-QB-Logo_New-Brand-Update_QB-DK-Blue.png00Chandreyee Dashttps://quartz.bio/wp-content/uploads/2026/05/2026-QB-Logo_New-Brand-Update_QB-DK-Blue.pngChandreyee Das2025-08-29 15:17:392026-05-22 16:02:58QuartzBio Platform Version 12.0.0: Large File Support, Dynamic Analytics, Richer Clinical Insights
On Demand
Duration: 30 minutes
What you’ll learn:
Your team is tasked with data storytelling.
Every day, you’re pressed to turn complex biomarker, clinical, and sample datasets into actionable insights. To stay competitive, your team needs to report findings in minutes, not hours or weeks.
Unlock the speed you need with QuartzBio’s AI Agents, which power our Biomarker and Sample Intelligence solutions by serving as secure, personalized assistants for stakeholders across the entire R&D value chain. They deliver 10x faster* insights within a unified, self-serve platform, amplifying the impact of every team member.
Join Bill Hall as he chats with these AI Agents, showing how generative AI saves time and powers collaboration across multiple teams:
Faster Operations: e.g., 10X faster identification of consented samples with mutation data, split by treatment arm
Faster Informatics & Data Management: e.g., automatic data ingestion, QC, and mapping; application of FAIR principles, access control, and automated workflows
Faster Translational Research: e.g., in minutes, perform statistical analyses of assay data, incorporating clinical metadata and contextual information
You’ll learn how QuartzBio’s approach transforms the way R&D teams work with 360° intelligence.
Who should attend:
Translational Scientists
Biomarker Operations and Biospecimen Operations Teams
Data Science and Bioinformatics Teams
R&D Information Technology (IT)
**QuartzBio internal study, comparing Agent Intelligence to traditional workflows and point solutions, as determined via time-motion analysis.
https://quartz.bio/wp-content/uploads/2025/08/QuartzBio-Webinar-10x-Faster-Data-to-Insights.jpg25002500QuartzBio Teamhttps://quartz.bio/wp-content/uploads/2026/05/2026-QB-Logo_New-Brand-Update_QB-DK-Blue.pngQuartzBio Team2025-08-08 13:27:532026-09-03 13:25:07Webinar — AI Agents in Action: 10X Faster Insights Across the R&D Ecosystem
The new ICH E6(R3) GCP guideline introduces significantly more detailed requirements around the integrity and governance of data assets and trial records, including biospecimens, their derivatives, and all associated clinical and assay data generated during trials.
To help precision medicine teams ensure they meet these new requirements, we have developed this compliance checklist. Using the QuartzBio Platform, with our solutions for Sample Intelligence and Biomarker Intelligence, can help you implement these checklist items and ensure compliance.
Check each completed item, get your score below, and contact us for next steps:
Your Readiness Score: 0 of 16
What’s your score? Rate your readiness:
0-5: Still using spreadsheets and emails? It’s not too late – QuartzBio’s technology can make digital transformation easy, accurate and fast.
6-11: You most likely have an ecosystem of point solutions to manage your data assets, but it can be a headache to ensure all these solutions are compliant. Let’s connect your point solutions across the precision medicine value chain for a scalable, platform approach to compliance.
12-16: Congratulations, you have a strong foundation of data integrity and governance! You’re ready to optimize risk-based management, leveraging insights across clinical programs, including from closed studies. Learn how QuartzBio’s platform accelerates your data-to-insights lifecycle by 2X or more.
Get in touch for personalized recommendations and a demo of our Precision Medicine AI Agent Platform:
https://quartz.bio/wp-content/uploads/2026/05/2026-QB-Logo_New-Brand-Update_QB-DK-Blue.png00Chandreyee Dashttps://quartz.bio/wp-content/uploads/2026/05/2026-QB-Logo_New-Brand-Update_QB-DK-Blue.pngChandreyee Das2025-05-23 11:10:552026-06-12 21:09:17What’s your ICH E6(R3) Readiness Score?
Time-saving global filters: Instead of applying the same filters across multiple charts in a dashboard, you can now apply dashboard-level common filters, and all visualizations will instantly reflect your filtered dataset.
Improve collaboration and onboarding with organizational sharing: New “share with all” functionality enables organization-level permissions. New users can access dashboards as soon as they log in.
Visualization engine enhancements:
Statistical tests, including parametric and nonparametric tests, for richer biomarker data analysis / visualization (Figure 1)
Sample testing status heatmap for rapid insights (Figure 2)
Figure 1. Statistical tests are now available, including statistical tests for boxplots: Compare boxplots within a series to determine if their mean difference is statistically significant.
Figure 2. Sample status heatmaps added as visualization options. Gain rapid insights into multiple sample statuses to track sample collection or testing, as part of our Sample Intelligence Solution.
I just read Microsoft’s latest Work Trend Index report, “The Year the Frontier Firm Is Born,” and it resonates deeply with the challenges and opportunities we’re seeing in precision medicine R&D.
The report highlights a seismic shift: the rise of AI agents isn’t just about automating tasks; it’s about fundamentally rewiring how businesses operate.
Key takeaways from the report include:
Intelligence on Tap: AI is becoming an abundant, on-demand resource, offering “digital labor” to bridge the gap between increasing business demands and human capacity.
Human-Agent Teams: The future isn’t human vs. machine, but human + machine. Teams will increasingly integrate AI agents as “digital colleagues,” shifting the focus from functional silos to outcome-driven “Work Charts”. This requires a new mindset, viewing AI not just as a tool, but a thought partner.
Every Employee an Agent Boss: Managing and directing AI agents will become a core skill across all levels, accelerating careers and enabling more strategic work earlier.
This vision of AI-augmented work mirrors the complexities we navigate daily in the precision medicine value chain.
Currently, getting answers often involves a complex “information ping-pong” across various teams and systems, delaying critical insights. Clinical trials generate vast amounts of data, yet extracting timely value remains a significant hurdle for many organizations.
At QuartzBio, we believe the future lies in connecting this intricate value chain. We envision a future empowered by a seamless, semi-autonomous system – the QuartzBio Platform. This network of specialized AI agents is designed not to replace human expertise, but to amplify it.
Our platform aims to:
Autonomously ingest and manage complex data streams across the R&D ecosystem.
Enable conversational interaction, allowing researchers and operational teams to interrogate data and receive insights in seconds, not weeks.
Proactively deliver rich, contextual information to support strategic decision-making.
Foster interoperability and collaboration, breaking down data silos.
By integrating human ingenuity with intelligent agents, we can shift the focus from manual processes to strategic insight generation, ultimately accelerating the delivery of novel treatments.
The “Frontier Firm” concept isn’t just a future hypothetical; it’s the operational model we are building towards in life sciences today.
https://quartz.bio/wp-content/uploads/2025/04/QB_LinkedIn_AI-Agents-Reshape_1200x1200_A_-1030x1030-1.jpg10301030Chandreyee Dashttps://quartz.bio/wp-content/uploads/2026/05/2026-QB-Logo_New-Brand-Update_QB-DK-Blue.pngChandreyee Das2025-04-29 12:32:272026-06-12 21:14:23The Dawn of the Frontier Firm: How AI Agents Are Reshaping Work & Precision Medicine
Missed our presentation at Bio-IT World?
Watch Tobi Guennel, Ph.D., QuartzBio’s Co-founder and Chief Technology Officer, demonstrate how a network of domain-specific AI agents, orchestrated by our first-in-class Virtual Assistant, empowers informatics, translational, and IT teams to conversationally explore and visualize clinical, sample, and biomarker data. Our agentic platform can perform tasks semi-autonomously based on expected events and observed data trends.
You’ll see how you can get from data to insights by generating analytics and visualizations in minutes instead of hours or days — accelerating study close and time-to-market.
https://quartz.bio/wp-content/uploads/2025/04/LinkedIn_Intel-at-Scale_1200x1200_Update-1.jpg12001200Chandreyee Dashttps://quartz.bio/wp-content/uploads/2026/05/2026-QB-Logo_New-Brand-Update_QB-DK-Blue.pngChandreyee Das2025-04-16 16:20:002026-07-08 15:47:16The QuartzBio AI Agent Network: Intelligence at Scale
Duration: 30 minutes, on demand
What you’ll learn:
R&D teams in biomarker-rich clinical trials are constantly chasing insights around a complex data ecosystem. By the time stakeholders find their data, gain access, ideate on the right analysis and get results, the chance to make impactful decisions may be over.
With QuartzBio’s AI Agent Platform, you can ask questions, get answers, and gain insights at the speed of decision-making.
Domain-specific AI agents, orchestrated by our Virtual Assistant, enable operations, translational, and informatics teams to conversationally interact with a connected ecosystem of biomarker, sample, and clinical data.
Join Bill Hall as he chats with the Virtual Assistant, conversationally extracting insights in seconds, achieving:
Amplified Operational Efficiency: e.g., “Show me biopsy samples from patients in the 70th percentile of JAK2 expression at baseline”
Autonomous Workflows & Interoperability: e.g., automatically ingesting and harmonizing assay data upon arrival from testing lab
Amplified Translational Research: e.g., ““Compare gene expression profiles for responders vs non-responders at baseline”
You’ll learn how QuartzBio’s approach transforms the way R&D teams work with 360° intelligence.
Who should attend:
Translational Scientists
Biomarker Operations and Biospecimen Operations Teams
Data Science and Bioinformatics Teams
R&D Information Technology (IT)
https://quartz.bio/wp-content/uploads/2025/04/LinkedIn_MAY-Webinar_1200x1200_OCT-Update-2.jpg12001200Chandreyee Dashttps://quartz.bio/wp-content/uploads/2026/05/2026-QB-Logo_New-Brand-Update_QB-DK-Blue.pngChandreyee Das2025-04-11 13:34:422026-08-27 16:09:02Webinar: QuartzBio AI Agents Accelerate Data-to-Insights
Watch the full episode:
Tobi Guennel, PhD, SVP of Product Innovation at QuartzBio, joins AI expert Srivatsan Nagaraja to discuss his insights on integrating AI into the precision medicine value chain in an episode of the Life Sciences D’n’A Podcast.
Tune in to learn about:
Leveraging AI and advanced analytics to improve clinical trial efficiency
Using AI agents to automate clinical trial operations
https://quartz.bio/wp-content/uploads/2025/03/QB_LinkedIn_Integration-AI-Podcast_1200x1200.jpg12001200Chandreyee Dashttps://quartz.bio/wp-content/uploads/2026/05/2026-QB-Logo_New-Brand-Update_QB-DK-Blue.pngChandreyee Das2025-03-27 19:07:382026-04-14 18:58:57Podcast: Integrating AI into Precision Medicine